So, this suggests that autophagy in cancer cells is a protective reaction to anti-tumor agents, and a disrupted autophagy pathway may enhance the cytotoxicity of LSD1 inhibitor in prostate cancer cells. Here, KDM1A is linked to prostate cancer.